Considering Harm Reduction as the Future of Doping Control Policy in International Sport

Quest

Volumn 61, Issue 2, 2009, Pages 180-190

  Kirkwood, Ken ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77954764375     PISSN: 00336297     EISSN: 15432750     Source Type: Journal    
DOI: 10.1080/00336297.2009.10483609     Document Type: Article

References (51)

1. Aitken, C., Delalande, C., & Stanton, K. (2002). Pumping iron, risking infection? Exposure to hepatitis C, hepatitis B and HIV among anabolic-androgenic steroid injectors in Victoria, Australia. Drug and Alcohol Dependence, 65, 303-308.
2. Barney, R.K., Wenn, S.R., & Martyn, S.G. (2002). Selling the five rings: The International Olympic Committee and the rise of Olympic commercialism. Salt Lake City: University of Utah Press.
3. Beamish, R. (1996). Pierre de Coubertin’s shattered dream. Queen’s Quarterly, 103(3), 487-501.
4. Beamish, R., & Borowy, J. (1988). Q. What do you do for a living? A. I’m an athlete. Kingston, ON, Canada: Queen’s University Sport Research Group.
5. Beauchamp, T.L., & Childress, J.F. (2001). Principles of biomedical ethics (5th ed.). Oxford, UK: Oxford University Press.
6. Brown, W.M. (1984). Paternalism, drugs, and the nature of sports. Journal of the Philosophy of Sport, XI, 14-22.
7. Brown, W.M. (2001). As American as Gatorade and apple pie. In W.J. Morgan, K.V. Meier, & A.J. Schneider (Eds.), Ethics in sport (pp. 142-168). Champaign, IL: Human Kinetics.
8. Burstyn, V. (1990). The sporting life. Saturday Night, 105, 42-50.
9. Butcher, R.B., & Schneider, A.J. (1998). Fair play as respect for the game. Journal of the Philosophy of Sport, XXV, 1-22.
10. Clark, A.S., & Henderson, L. (2003). Behavioral and physiological responses to anabolic-androgenic steroids. Neuroscience and Biobehavioral Reviews, 27, 413-436.
11. Dassler, H. (1980). Sport and industry. Olympic Review, 147-148, 26-28.
12. Ekblom, B.T. (2000). Blood boosting and sport. Bailliere’s Clinical Endocrinology and Metabolism, 14(1), 89-98.
13. Emanuel, E.J. (2004). Ending concerns about undue inducement. The Journal of Law, Medicine & Ethics, 32(1), 100-105.
14. Erill, S. (2000). The doping of fairness. Lancet, 356(9235), 1122.
15. Evans, N. (2004). Current concepts in anabolic-androgenic steroids. American Journal of Sports Medicine, 32(2), 534-542.
16. Filipp, F. (2007). Is science killing sport? EMBO Reports, 8(5), 433-435.
17. Finley, M.I. (1976). The Olympic Games: The first thousand years. Toronto, ON: Clarke & Irwin.
18. Grady, C. (2001). Money for research participation: Does it jeopardize informed consent? The American Journal of Bioethics, 1(2), 40-44.
19. Harris, J. (2004). On cloning. London: Routledge.
20. Hausmann, R., Hammer, S., & Betz, P. (1998). Performance enhancing drugs (doping agents) and sudden death: A case report and review of the literature. International Journal of Law and Medicine, 111, 261-264.
21. Hoberman, J. (1995). Listening to steroids. The Wilson Quarterly, 19(1), 35-44.
22. Hoberman, J. (2001). Offering the illusion of reform on drugs. In P. Donnelly (Ed.), Taking sport seriously (pp. 28-30). Toronto, ON, Canada: Thompson Educational Press.
23. Hoberman, J. (2002). Sports physicians and the doping crisis in elite sport. Clinical Journal of Sport Medicine, 12(4), 203-208.
24. Houlihan, B. (1999). Doping in sport and the development of anti-doping policy. London: Council of Europe.
25. Hunter, M. (2002). Athletes risk their lives by routine use of performance enhancing drugs says BMA. British Medical Journal, 324, 870.
26. Kalinski, M. (2003). State-sponsored research on creatine supplements and blood doping in elite Soviet sport. Perspectives in Biology and Medicine, 46(3), 445-451.
27. Kirkwood, K.W. (2004). Good as gold: Commercial aspects of WADA’s development. In K.B. Wamsley, S.G. Martyn, & R.K. Barney (Eds.), Cultural relations old and new: The transitory Olympic ethos (pp. 199-212). London, ON, Canada: International Centre for Olympic Studies.
28. Knight, T. (2002, 30 January). Drugs in sport: New blood booster 10 times stronger than EPO. The London Telegraph, p. A2.
29. Kutscher, E.C., Lund, B.C., & Perry, PJ. (2002). Anabolic steroids: A review for the clinician. Sports Medicine (Auckland, N.Z.), 32(5), 285-296.
30. Luschcen, G. (1977). Cheating in sport. In D. Landers (Ed.), Social problems in athletics (pp. 66-77). Urbana: University of Illinois Press.
31. Luschen, G. (1993). Doping in sport: The social structure of a deviant subculture. Sport Science Review: Sport Sociology, 2(1), 92-106.
32. MacIntyre, A. (1984). After virtue. South Bend, IN: Notre Dame Press.
33. Madea, B., & Grellner, W. (1998). Long-term cardiovascular effects of anabolic steroids. Lancet, 352(9121), 33-34.
34. Maron, B. (2003). Sudden death in young athletes. The New England Journal of Medicine, 349(11), 1064-1075.
35. Meier, K. (1984). Axiological issues in sport. Journal of the Philosophy of Sport, XI, 1-5.
36. Mottram, D.R. (2003). Drugs in sport. New York: Routledge.
37. Parssinen, M., & Seppala, T. (2002). Steroid use and long-term health risks in former athletes. Sports Medicine (Auckland, N.Z.), 32(2), 83-94.
38. Pope, H.G., & Katz, D.L. (1988). Affective and psychotic symptoms associated with anabolic steroid use. The American Journal of Psychiatry, 145, 489-490.
39. Pope, H.G., & Katz, D.L. (1994). Psychiatric and medical effects of anabolic steroids: A controlled study of 160 athletes. Psychiatry, 51, 375-382.
40. Roberts, R., & Olson, J. (1989). Winning is the only thing: Sports in America since 1945. Baltimore: The Johns Hopkins University Press.
41. Schneider, A.J., & Butcher, R.B. (2000). A philosophical overview of the arguments on banning doping in sport. In T. Tännsjö & C. Tamburini (Eds.), Values in sport: Elitism, nationalism, gender equity and the scientific manufacture of winners (pp. 185-199). New York: E&F Spon.
42. Simon, R.L. (1984). Good competition and drug-enhanced performance. Journal of the Philosophy of Sport, XI, 6-13.
43. Smith, G.S. (1996). Roar of the greasepaint, the smell of the crowd? Will the Olympics become more and more a marketer’s emporium? Queen’s Quarterly, 103(3), 502-519.
44. Todd, T. (1987). Anabolic steroids: The gremlins of sport. Journal of Sport History, 14(1), 87-107.
45. Tokish, J.M., Kocher, M.S., & Hawkins, R.J. (2004). Ergogenic aids: A review of basic science, performance, side effects, and status in sports. American Journal of Sports Medicine, 32(6), 1543-1553.
46. Ungerleider, S. (2001). Faust’s gold: Inside the East German doping machine. New York: St. Martin’s Press.
47. Veatch, R.M. (1995). Abandoning informed consent. The Hastings Center Report, 25(2), 5-12.
48. Voet, W. (2001). Breaking the chain. London: Yellow Jersey Press.
49. World Anti-Doping Agency. (2003a). Independent observer report: Tour de France 2003. Montreal, QC, Canada: Author.
50. World Anti-Doping Agency. (2003b). World anti-doping code. Montreal, QC, Canada: Author.
51. World Anti-Doping Agency. (2004). Guidelines for urine sample collection, version four. Montreal, QC, Canada: Author.